Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.42 -0.38 (-0.98%) Market Cap: 5.61 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.93 GF Score: 70/100

Ionis Pharmaceuticals Inc at William Blair Growth Stock Conference (Virtual) Transcript

Jun 01, 2021 / 03:00PM GMT
Release Date Price: $36.74 (-1.37%)
Myles Robert Minter
William Blair & Company L.L.C., Research Division - Analyst

Thanks, everyone, for joining us here at the William Blair Growth Stock Conference. My name is Myles Minter, I'm a biotech research analyst here at the firm who covers Ionis Pharmaceuticals. Just before we kick things off for this fireside chart, I'd like to remind everyone that there's a complete list of research disclosures available at williamblair.com that you can peruse at your own leisure. And throughout the fireside chat, we have prepared questions. But also if you would like to submit your own Q&A, please do so in the box below, and we will do our best to get those answered for you.

And with that, there's a small change to the schedule this morning. Beth Hougen, the CFO of the company, unfortunately, had a family emergency that she's attending to. We wish her all the best. But at very short notice and early notice, may I say, Eric Swayze, the Executive Vice President of Research at the company has agreed to join us this morning. So thankful for that, Eric.

And perhaps we can just kick things

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot